Financial statements Ozein Bio-Technology Ltd.
Balance sheet data of OZEIN BIO-TECHNOLOGY LTD.
|
Year
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|
| Total assets | 7 899 858,76 | 7 643 690,63 | 7 706 714,96 | 7 439 516,50 |
| A. Fixed assets | 5 870 246,92 | 6 338 347,09 | 6 260 086,11 | 6 086 983,07 |
| B. Current assets | 2 029 611,84 | 1 305 343,54 | 1 446 628,85 | 1 352 533,43 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 7 899 858,76 | 7 643 690,63 | 7 706 714,96 | 7 439 516,50 |
| A. Equity | 4 608 100,26 | 5 473 254,88 | 5 506 878,30 | 5 016 394,90 |
| B. Liabilities and provisions for liabilities | 3 291 758,50 | 2 170 435,75 | 2 199 836,66 | 2 423 121,60 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 3 291 758,50 | 2 170 435,75 | 2 199 836,66 | 2 423 121,60 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.